ArticleGynecologic oncology2026

Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly diagnosed advanced-stage epithelial ovarian cancer: the AdORN study.

Stéphanie Gaillard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.